Cat. #156503

p65-glutathione S-transferase (GST) fusion Protein

Cat. #: 156503

Availability: Please enquire for quantities and pricing

Target: p65/RelA

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Enquire or request a quote

Contributor

Inventor: Lawrence Pfeffer

Institute: The University of Tennessee Health Science Center (UTHSC)

Tool Details

Handling

Target Details

References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

Tool name: p65-glutathione S-transferase (GST) fusion Protein
Alternate name: RelA
Research fields: Apoptosis and autophagy;Immunology
Sequence: MDDLFPLIFPSEPAQASGPYVEIIEQPKQRGMRFRYKCEGRSAGSIPGERSTDTTKTHPTIKINGYTGPGTVRISLVTKDPPHRPHPHELVGKDCRDGYYEADLCPDRSIHSFQNLGIQCVKKRDLEQAISQRIQTNNNPFHVPIEEQRGDYDLNAVRLCFQVTVRDPAGRPLLLTPVLSHPIFDNRAPNTAELKICRVNRNSGSCLGGDEIFLLCDKVQKEDIEVYFTGPGWEARGSFSQADVHRQVAIVFRTPPYADPSLQAPVRVSMQLRRPSDRELSEPMEFQYLPDTDDRHRIEEKRKRTYETFKSIMKKSPFNGPTEPRPPTRRIAVPTRNSTSVPKPAPQPYTFPASLSTINFDEFSPMLLPSGQISNQALALAPSSAPVLAQTMVPSSAMVPLAQPPAPAPVLTPGPPQSLSAPVPKSTQAGEGTLSEALLHLQFDADEDLGALLGNSTDPGVFTDLASVDNSEFQQLLNQGVSMSHSTAEPMLMEYPEAITRLVTGSQRPPDPAPTPLGTSGLPNGLSGDEDFSSIADMDFSALLSQISS
Source: p65 (RelA) cDNA was subcloned into the HindIII and EcoRI sites of pGEX-KG vector and transformed into E.coli
Target: p65/RelA
Description: NF-B is a transcription factor involved in regulation of expression of the genes involved in cell survival, immunity, inflammation, differentiation and apoptosis in all cell types. p65/RelA (reticuloendotheliosis viral oncogene homolog A, RelA) is expressed as a subunit of NF-B and can be great tool to study different biological processes in human body.

Handling

Storage conditions: -80° C
Shipping conditions: Dry Ice

Target Details

Target: p65/RelA

References

Yang et al. 2005. J Biol Chem. 280(36):31530-6. PMID: 16009713.